Lung Cancer Biobank Study for Newly Diagnosed Patients
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial collects blood and tissue samples from people newly diagnosed with lung cancer (NSCLC or CPC) to study the disease over time. It helps researchers understand how different treatments affect the cancer and the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older)
- You have been newly diagnosed with non-small cell lung cancer (NSCLC) or small cell lung cancer (CPC)
- You are being treated at Nantes University Hospital
- You are starting a systemic treatment (chemotherapy, immunotherapy, targeted therapy, or similar)
- You have not received any previous treatment for lung cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study builds a detailed lung-cancer database by collecting clinical and lab information from people newly diagnosed. It aims to help doctors better understand lung cancer and how patients are treated from the start.
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
This study collects medical data and samples from people with newly diagnosed bronchial cancer to learn more about the disease. You may be able to join if you have not yet started treatment for this cancer.
This study checks whether “liquid biopsies” (blood tests) can help monitor advanced non-small-cell lung cancer. It looks at different patient groups based on timing and tumor features, aiming to make cancer tracking easier and less invasive.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.